These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

804 related articles for article (PubMed ID: 34659224)

  • 1. Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Triple-Negative Breast Cancer.
    Qiu P; Guo Q; Yao Q; Chen J; Lin J
    Front Immunol; 2021; 12():736030. PubMed ID: 34659224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An exosome-related long non-coding RNAs risk model could predict survival outcomes in patients with breast cancer.
    Qiu P; Guo Q; Lin J; Pan K; Chen J; Ding M
    Sci Rep; 2022 Dec; 12(1):22322. PubMed ID: 36566321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an IFNγ response-related signature for predicting the survival of cutaneous melanoma.
    Hu B; Wei Q; Li X; Ju M; Wang L; Zhou C; Chen L; Li Z; Wei M; He M; Zhao L
    Cancer Med; 2020 Nov; 9(21):8186-8201. PubMed ID: 32902917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an exosome-related signature associated with prognosis and immune infiltration in breast cancer.
    Guo Q; Pan K; Qiu P; Liu Z; Chen J; Lin J
    Sci Rep; 2023 Oct; 13(1):18198. PubMed ID: 37875600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic stratification based on microenvironment immune types and PD-L1 for tailoring therapeutic strategies in bladder cancer.
    Lyu X; Wang P; Qiao Q; Jiang Y
    BMC Cancer; 2021 May; 21(1):646. PubMed ID: 34059019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of a 14 immune-related gene pair signature to predict the prognosis and immune features of gastric cancer.
    Liu C; Chen B; Huang Z; Hu C; Jiang L; Zhao C
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107074. PubMed ID: 33049494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 8. Development and Clinical Validation of Novel 8-Gene Prognostic Signature Associated With the Proportion of Regulatory T Cells by Weighted Gene Co-Expression Network Analysis in Uterine Corpus Endometrial Carcinoma.
    Liu J; Geng R; Yang S; Shao F; Zhong Z; Yang M; Ni S; Cai L; Bai J
    Front Immunol; 2021; 12():788431. PubMed ID: 34970268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An exosome-based specific transcriptomic signature for profiling regulation patterns and modifying tumor immune microenvironment infiltration in triple-negative breast cancer.
    Wang H; Wang R; Luo L; Hong J; Chen X; Shen K; Wang Y; Huang R; Wang Z
    Front Immunol; 2023; 14():1295558. PubMed ID: 38124743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
    Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
    Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A TP53-based immune prognostic model for muscle-invasive bladder cancer.
    Li H; Lu H; Cui W; Huang Y; Jin X
    Aging (Albany NY); 2020 Dec; 13(2):1929-1946. PubMed ID: 33323544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel immune-related prognostic index for predicting breast cancer overall survival.
    Yu X; Guo J; Zhou Q; Huang W; Xu C; Long X
    Breast Cancer; 2021 Mar; 28(2):434-447. PubMed ID: 33146847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the expression of the immune checkpoint molecules PD-1, CTLA4, TIM-3 and LAG-3 across different cancers in relation to treatment response, tumor-infiltrating immune cells and survival.
    Tu L; Guan R; Yang H; Zhou Y; Hong W; Ma L; Zhao G; Yu M
    Int J Cancer; 2020 Jul; 147(2):423-439. PubMed ID: 31721169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LCP1 correlates with immune infiltration: a prognostic marker for triple-negative breast cancer.
    Pan S; Wan M; Jin H; Ning R; Zhang J; Han X
    BMC Immunol; 2024 Jul; 25(1):42. PubMed ID: 38977952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a survival-related signature for sarcoma patients through integrated transcriptomic and proteomic profiling analyses.
    Zhang B; Yang L; Wang X; Fu D
    Gene; 2021 Jan; 764():145105. PubMed ID: 32882333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancer.
    Tan W; Liu M; Wang L; Guo Y; Wei C; Zhang S; Luo C; Liu N
    BMC Cancer; 2021 Feb; 21(1):126. PubMed ID: 33549054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
    Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
    Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast Cancer.
    Sivapiragasam A; Ashok Kumar P; Sokol ES; Albacker LA; Killian JK; Ramkissoon SH; Huang RSP; Severson EA; Brown CA; Danziger N; McGregor K; Ross JS
    Cancer Med; 2021 Jan; 10(1):53-61. PubMed ID: 33314633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
    Xiao R; Yang M; Tan Y; Ding R; Li D
    Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma.
    Liu D; Yang X; Wu X
    Front Immunol; 2021; 12():663495. PubMed ID: 34025664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.